XML 90 R56.htm IDEA: XBRL DOCUMENT v3.25.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of equity method investments (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]                      
Equity attributable to investee $ (497,583)       $ (497,583)           $ 291,117
Revenues 199,305   $ 363,268   637,222   $ 1,151,943        
Income (loss) from continuing operations (148,852)   (100,049)   (645,506)   (48,510)        
Net income (loss) attributable to investees $ (284,397)   $ (73,823)   $ (767,166)   $ (10,287)        
FRG                      
Schedule of Equity Method Investments [Line Items]                      
Current assets   $ 877,471       $ 877,471         961,787
Noncurrent assets   2,936,951       2,936,951         3,131,506
Current liabilities   571,661       571,661         720,510
Noncurrent liabilities   2,641,119       2,641,119         2,640,805
Revenues   767,404   $ 1,038,686   2,383,350     $ 3,259,396    
Cost of revenues   491,702   632,623   1,503,104     1,288,751    
Income (loss) from continuing operations   0   0   (1,175)     0    
FRG | Investee                      
Schedule of Equity Method Investments [Line Items]                      
Equity attributable to investee   601,642       601,642         731,978
Net income (loss) attributable to investees   (111,881)   (50,796)   (300,720)     (159,824)    
B&W                      
Schedule of Equity Method Investments [Line Items]                      
Current assets   574,562       574,562         497,593
Noncurrent assets   274,560       274,560         278,105
Current liabilities   333,890       333,890         350,197
Noncurrent liabilities   713,576       713,576         625,851
Noncontrolling interest   585       585         611
Revenues   233,642   291,515   668,365     769,197    
Cost of revenues   179,152   228,352   509,779     600,441    
Income (loss) from continuing operations   25,222   594   (44,843)     (14,381)    
Net income (loss) attributable to investees   25,364   (5,012)   (54,151)     (11,827)    
B&W | Investee                      
Schedule of Equity Method Investments [Line Items]                      
Equity attributable to investee   (198,929)       (198,929)         (200,961)
Net income (loss) attributable to investees   25,315   (5,088)   (57,972)     $ (15,563)    
Synchronoss Technologies, Inc.                      
Schedule of Equity Method Investments [Line Items]                      
Current assets   75,520       75,520         82,002
Noncurrent assets   220,152       220,152         228,335
Current liabilities   42,401       42,401         47,697
Noncurrent liabilities   210,152       210,152         164,706
Revenues   43,458   41,019   127,825   $ 124,256      
Cost of revenues   10,401   11,488   30,916   34,447      
Synchronoss Technologies, Inc. | Investee                      
Schedule of Equity Method Investments [Line Items]                      
Equity attributable to investee   43,119       43,119         97,934
Net income (loss) attributable to investees   78   (10,979)   (32,582)   $ (40,297)      
Other Equity Investments                      
Schedule of Equity Method Investments [Line Items]                      
Current assets   239,004       239,004         279,810
Noncurrent assets   563,871       563,871         622,632
Current liabilities   222,125       222,125         185,925
Noncurrent liabilities   146,226       146,226         236,829
Preferred stock   0       0         4,500
Revenues   111,909   36,107   372,418       $ 111,542  
Cost of revenues   76,286   20,492   279,426       73,244  
Other Equity Investments | Investee                      
Schedule of Equity Method Investments [Line Items]                      
Equity attributable to investee   434,524       434,524         $ 475,188
Net income (loss) attributable to investees   $ (4,273)   $ 6,586   $ (14,229)       $ 3,701